Hormonal implants: contraception for a new century (Q38568632)

4 September 2017

1 reference

title

Hormonal implants: contraception for a new century (English)

1 reference

4 September 2017

1 reference

P D Darney

1

1 reference

PubMed ID

8178903

4 September 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

American Journal of Obstetrics and Gynecology

4 September 2017

1 reference

4 September 2017

170

1 reference

4 September 2017

1536-1543

1 reference

4 September 2017

5 Pt 2

1 reference

Fertility control in women with a progestogen released in microquantities from subcutaneous capsules

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Long-term reversible contraception with levonorgestrel-releasing Silastic rods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Insertion site complications during the first year of NORPLANT use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

International experience with NORPLANT and NORPLANT-2 contraceptives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Copper T IUD use and ectopic pregnancy rates in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Contraception and ectopic pregnancy risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Changes in carbohydrate metabolism during 30 months on Norplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Clinical chemistry in women treated with progestogen implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Three-year experience with NORPLANT subdermal contraception.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

The significance of bleeding patterns in Norplant implant users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Menstrual blood loss with contraceptive subdermal levonorgestrel implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

The clinical performance of NORPLANT implants over time: a comparison of two cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

A four-year clinical study of NORPLANT implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Recovery of fertility and outcome of planned pregnancies after the removal of Norplant subdermal implants or Copper-T IUDs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Acceptance and perceptions of NORPLANT among users in San Francisco, USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Clinical trial with 3-keto-desogestrel subdermal implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Clinical results with subcutaneous implants containing 3-keto desogestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Release kinetics of 3-keto-desogestrel from contraceptive implants (Implanon) in dogs: comparison with in vitro data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Clinical evaluation of the Capronor contraceptive implant: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Contraceptive efficacy of bioabsorbable pellets of norethindrone (NET) as subcutaneous implants: Phase II clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2905016-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(94)05016-7

1 reference

4 September 2017

1 reference

PubMed ID

8178903